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Abstract 
Generation of artificial metalloenzymes has gained much inspiration from the general 
understanding of natural metalloenzymes. Over the last decade, a multitude of methods 
generating transition metal-protein hybrids have been developed and many of these new-to-
nature constructs catalyse reactions previously reserved for the realm of synthetic chemistry. 
This perspective will focus on artificial metalloenzymes incorporating 4d and 5d transition 
metals. It aims to summarise the significant advances made to date and asks whether there are 
chemical strategies, used in nature to optimise metal catalysts, that have yet to be fully 
recognised in the synthetic enzyme world, particularly whether artificial enzymes produced to 
date fully take advantage of the structural and energetic context provided by the protein. 
Further, the argument is put forward that, based on precedence, in the majority of naturally 
evolved metalloenzymes the direct coordination bonding between the metal and the protein 
scaffold is integral to catalysis. Therefore, the protein can attenuate metal activity by 
positioning ligand atoms in the form of amino acids, as well as making non-covalent 
contributions to catalysis, through intermolecular interactions that pre-organise substrates and 
stabilise transition states. This highlights the often neglected but crucial element of natural 
systems that is the energetic contribution towards activating metal centres through protein fold 
energy. Finally, general principles needed for a different approach to the formation of artificial 
metalloenzymes are set out, utilizing direct coordination inspired by the activation of an 
organometallic cofactor upon protein binding. This methodology, observed in nature, delivers 
true interdependence between metal and protein. When combined with the ability to efficiently 
evolve enzymes, new problems in catalysis could be addressed in a faster and more specific 
manner than with simpler small molecule catalysts.  
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Introduction 
Metalloenzymes have been prominent in the field of enzyme engineering since its emergence 
some 40 years ago, at the birth of protein/enzyme engineering.(1, 2) Metal ions or co-factors 
in solution have an intrinsic chemistry that can be catalytic and these are accessible to detailed 
mechanistic study. These properties mean that co-localization of substrate and metal within a 
peptidic scaffold can be sufficient in forming an artificial metalloenzyme (ArM), without 
further influence from the protein on the catalytic mechanism. With the advent of modern 
protein engineering and design technologies, ArMs were developed by incorporating metal 
binding sites in or adjacent to hydrophobic pockets. While the resulting ArMs were active, they 
often displayed low efficiency and specificity. Therefore, directed evolution (i.e. iterative 
rounds of mutagenesis and selection for activity, Figure 1) has become a key step in creating 
enzymes with new and useful properties. The choice of starting point for such a forced 
evolution campaign, in this case the metal-protein complex formed initially, is of great 
importance. Since any particular enzyme follows a unique evolutionary trajectory as new 
mutations move it along the fitness landscape towards (potentially local) maxima, choice of 
the starting point may directly predetermine the result. By nature of the selection process, it is 
further possible, that trajectories leading to the global maximum fall beneath the cut-off limit 
for further evolution, becoming inaccessible. For instance, a mutation introduced in the first 
round of mutagenesis may lead to a destabilisation of the protein at assay conditions, causing 
that initial variant to be discarded through selection. However, a compensating mutation to that 
variant in a subsequent round of mutagenesis could result in an enzyme which is stable, active 
and closer to a global fitness maximum. Finally, not every method of generating ArMs may be 
compatible with current methods for directed evolution and therefore limit the extent of 
evolution that can be achieved. 
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Figure 1 | The general overview of a directed evolution campaign for artificial metalloenzymes. | The 
Darwinian algorithm can be reproduced in the laboratory, greatly increasing the speed of evolution. Mutagenesis 
methods introduce mutations with various levels of randomness, depending on the method used, to the starting 
point gene, forming a gene library. This library can then be expressed in a manner that couples expression products 
and genetic sequence information to yield the different proteins. Upon addition of the metal cofactor, the artificial 
metalloenzymes are formed and can be selected for improved variants in regard to desired parameters (reaction 
rates, yield, stereoselectivity, stability etc.). The metal modification step must itself clearly be efficient and high 
yielding to avoid limiting the library size at that stage. The sequence information of the improved candidates is 
recovered and can be subjected to further rounds of directed evolution.  
In this perspective, different routes towards artificial metalloenzymes are considered in the 
context of the starting protein scaffold as well as the type of catalytic centre and reactions 
involved. Advances in artificial metalloenzymes have recently been reviewed and the reader is 
referred to these for further details of the strategies used to find new systems.(3–5) This article 
aims to provide an overview of the strengths and weakness of these different approaches and 
to provide a perspective of some challenges that remain. 
Why Do We Want New Artificial Metalloenzymes? 
One particular area that will greatly impact chemical production on this planet is synthetic 
biology. Replacing synthetic catalysts, acting on petrochemical feedstocks in non-aqueous 
solvents, with biocatalytic systems working in water with simple carbon neutral feedstocks 
(CO2 even?) is clearly highly desirable. But why engineer new enzymes, particularly using 
expensive and relatively scarce transition metals, when the ability to find new catalysts 
amongst gene products from all corners of the biological world has developed at staggering 
pace?(6–8) As a consequence of the latter, any target chemical can conceivably be obtained by 
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recombining pre-existing metabolic pathways.(9) What will new and unnatural 
metalloenzymes provide? 
One clear feature is orthogonality – the objective of introducing functionality into a cell that 
has no counterpart in the natural world could provide chemistry that biology cannot currently 
catalyse – alkene metathesis for example. As there is a limit to the number of additional 
transformations a viable cell will perform, these orthogonal reactions may allow access to much 
shorter, and therefore more efficient, pathways. If not for a synthetic purpose, one could also 
imagine orthogonal catalytic chemistry providing a diagnostic or reporter output without 
interference from the host endogenous processes. For it to be truly orthogonal, it is difficult to 
imagine evolving a new enzyme based around metals already abundant in nature and already 
used as catalysts in biology. The transition metals used by nature are very carefully controlled 
by acquisition and regulatory networks that ensure catalytic metal ions are not free to operate 
outside the endogenous metabolism. Therefore, there is significant advantage in trying to 
introduce metals that biology currently has no evolved means of metabolising. This work 
therefore focuses primarily on non-biological transition metal co-factors as a route to 
introducing novel orthogonal activity into a biologically viable system. 
Evolutionary Routes to Optimised Artificial Metalloenzymes 
Natural evolution has provided numerous examples of metal ions used by enzymes for a 
plethora of different catalytic purposes. Rigorous mechanistic and structural biochemistry has 
advanced understanding of the mechanistic detail of metalloenzyme activity significantly, to 
the point that a few underpinning principles can be identified, linking protein structure and 
thermodynamics to catalytic activity of metal centres. Together with the knowledge garnered 
from extensive research on transition metal catalysts, it is possible to establish key properties 
desirable for novel ArMs. 
Considerations on Protein-Substrate Interactions 
As mentioned above, the ability of enzymes to organise reactants cooperatively can in itself 
give rise to enhanced activity over background rates in solution and in highly evolved systems 
this may even be the greatest factor driving increased reaction rates. It is important to realise 
that while metal-substrate proximity may be enough to confer reactivity, directional metal-
substrate orbital overlap also plays a crucial role in activating the substrate to react. Indeed, it 
is via the formation of metal-ligand/substrate molecular orbitals that the substrate chemistry is 
attenuated by the presence of the metal and that catalytic reactivity can be achieved. Significant 
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computational advancements have been made in the in-silico design of catalytic metal binding 
sites(10, 11) and the mechanistic understanding of reported ArMs.(12–15) However, given the 
lack of reliable parameters for defining transition metal bonding, and the immense complexity 
of the many low energy interactions that determine the coupling of protein folding to the 
binding of small molecules, it is beyond current computational capabilities to predict what 
primary sequence and cofactors are necessary to achieve the optimal arrangement for metal 
catalysis. It therefore becomes important to have a malleable, promiscuous starting system that 
can be used to sample a large space of different structures.(16) Hence, while choosing proteins 
with well-defined properties and unique structures has some advantages from a design point of 
view, starting points that do not fold into one specific structure may be desirable, since they 
are not as closely constrained by any one particular energy well. For similar reasons, in 
choosing a particular chemical strategy for introducing a metal cofactor into the protein, it 
becomes essential to use a method that allows for high throughput selection or screening.(17) 
Considerations on Metal Chemistry in Proteins 
In addition to sampling sequence space to optimize the geometrical factor, protein evolution 
offers the unique possibility of sampling transition metal chemistry by poising the metal in 
energized states. In small molecule transition metal catalysis, ligands will arrange around the 
metal centre to maximise bonding interactions and reach a thermodynamic minimum. In order 
to maintain the ligand exchange necessary for catalysis, some ligands tend to be weakly 
bonding, with the presence of strongly bonding ligands (for instance water or hydroxide) being 
a major factor in catalyst poisoning. In enzymes however, the intramolecular bonds generated 
within the whole protein scaffold can be used to place and maintain coordinating atoms from 
amino acids. These interactions can be seen as the second coordination sphere, shaping the 
metal complex and potentially leaving the first sphere ligand atoms in a suboptimal 
configuration around the metal centre so that the energy of the resulting complex is not at a 
minimum on the coordination energy landscape. The stabilisation of this complex is made 
possible by the favourable intramolecular peptidic interactions (i.e. protein fold energy) 
offsetting the  steric and or/electronic distortion of the optimum geometry.(18) These 
energized, or entatic, states have a reactivity that is not easily realized in conventional, synthetic 
metal catalysts, if it is possible at all.(19) This effect is most easily visualised by considering 
the common biological process of activation of inert co-factors by alteration of coordination 
upon binding to their respective apoenzymes. For instance, on their own the cobalt metallo-
organic cofactor, vitamin B12, and methionine synthase are catalytically inert; upon protein-
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cofactor binding and coordination of the cobalt centre to a specific histidine, methyl transfer 
activity is unmasked with great control and substrate specificity.(20–22) Applying this 
principle, it can be envisioned that even with the limited donor atoms available to proteins, a 
vast number of different complexes with different chemistries can be accessed, because the 
exact positioning as well as characteristics of the ligands dictate metal properties such as 
electron density, redox potential, Lewis acidity and ligand exchange rates. Further, the metal 
cofactor does not need to be a bare metal ion but could be incorporated with other ligands 
already attached. Interaction between these ligands (for instance π-π stacking with an arene 
ligand) and the protein can be relayed to the metal centre and allow for an even finer tuning of 
the metal centre. Again, current possibilities for design are insufficient to predict these effects 
which can be very subtle, highlighting the need for biochemical high throughput screening 
methods. 
The Optimal Method of ArM Formation 
The above considerations define a range of requirements for potential methods of forming 
ArMs. Primarily, there needs to be a direct connection between the protein scaffold and the 
metal ion in the form of at least one coordination bond, not only for localisation but also for 
poising the metal reactivity. As will be detailed below, most of the successful methods of 
generating ArMs published to date are efficient but rely on fully saturated, catalytically active 
co-factors such as commercial transition metal catalysts decorated with a linker moiety. These 
cannot make use of the protein fold energy to optimize the chemical process of catalysis, a 
potential factor in why directed evolution campaigns of ArMs have been of limited success. 
Whereas improvements in enantioselectivity and turnover number have been reported, which 
can be traced to substrate binding and the hydrophobic micro-environment respectively,(23–
26) significant increases in the chemical turnover rate (in many systems characterised by the 
initial kcat) from the free cofactor to the formed ArM have so far been limited. Small changes 
in kcat can be explained by organisational effects and indirect interactions with the substrate 
orbitals, such as charge compensation. As demonstrated by Hilvert et al., significant increases 
in kcat have been shown to be possible by fine tuning the actual centre of reaction, which is the 
first coordination sphere of the metal complex.(27) From the perspective of the protein 
scaffold, the formation of an entatic state requires the peptide to be at least partially folded 
before binding the metal, the more defined the fold, the greater the ability of the fold to energise 
the metal complex. This is in contrast to the desirable dynamic system for the evolutionary 
process. A potential compromise can be struck by using a starting scaffold that is partially 
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folded as the apoprotein and upon cofactor binding rigidifies to a completely folded form. The 
initial folding energy can be used to poise the metal in an activated state, while the folding 
process occurring during cofactor binding allows for the system to adapt during directed 
evolution. Once the ArM becomes more specialised after rounds of evolution, the apoprotein 
will probably approach a more fully folded form, yielding an ArM after cofactor addition that 
is less promiscuous but contains a more energized and active metal centre. 
To summarize, the number of different complex chemical factors required of ArMs demand 
the use of directed evolution in order to form enzymes with industrially and medically relevant 
properties. In order to ensure a high level of engineerability, an optimal methodology for 
combining 4d and 5d metals starts with a highly promiscuous and malleable holoprotein that 
further has dative bonds between the metal ion and the peptidic moieties. A further point 
considering the cofactor attachment point is that the cofactor should be in a deep cleft within 
the protein topology rather than at the surface. This is to allow the protein to maximise substrate 
binding and secondary transition state stabilising effects, as well as second sphere interactions 
influencing the metal complex.  
Strategies for Generating Artificial Metalloenzymes 
Artificial metalloenzymes are generated either from the combination of an unnatural transition 
metal cofactor being introduced into a protein scaffold or a natural metalloprotein being 
evolved in a laboratory to enhance or alter its natural catalytic reactivity. A detailed review of 
the field of the directed evolution of natural metalloproteins is out of the scope of this 
perspective, however, the engineering and evolutionary approaches developed by Frances 
Arnold, and applied to haem metalloproteins (e.g. Cytochrome P450) is particularly 
noteworthy and applicable when evolving unnatural metal-protein hybrid catalysts.(28–30) 
Four successful strategies have been employed to localise an unnatural metal to a well-defined 
location within a protein matrix. 
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Metal Ion Substitution in Natural Enzymes 
 
Figure 2 | Schematic representation of metal substitution | The natural cofactor (red) can be substituted with 
a suitable unnatural cofactor (blue). This may include the bare metal ion or larger cofactors such as heme. 
Natural metal cofactors can be found in proteins encapsulated by ligands supplied by the 
protein or with non-protein ligands also coordinated. This enables two different methods of 
metal substitution: (i) substituting the metal ion in a protein defined coordination site or (ii) 
substituting the metal ion in a natural metal-organic cofactor (e.g. haem) (Figure 2). 
Many ArMs have been generated by substituting the catalytic Zn(II) ion located in a His3 
binding site of carbonic anhydrase with different metals, for example, Coleman et al. reported 
esterase activity of a Co(II) substituted carbonic anhydrase.(31) Replacement with different 
Rh(I) species has also been explored, with catalytic hydrogenation(32) and 
hydroformylation(33) demonstrated. However, these rhodium metalloenzymes have a much 
slower activity than commercial small molecule rhodium catalysts alone. Although in these 
examples it is demonstrated that unnatural metal complexes can coordinate to the natural Zn(II) 
binding site, relatively low catalytic activity is observed. The highly evolved Zn binding site 
contains a complex secondary sphere architecture, in order to modulate the Lewis acidity of 
Zn. The chemically different demands for rhodium catalysed hydrogenation/hydroformylation 
reactions will therefore not be met in this system. Further, evolution of such a specialised 
system may be difficult. 
Hartwig et al. reported taking the metal-organic cofactor haem and substituting Fe for a range 
of different 4d and 5d metals (including Rh, Ru, Ir and Ag).(34) In one particularly 
comprehensive example, an Ir(Me) porphyrin was incorporated into the cytochrome P450 
enzyme CYP119 and catalytic functionalisation of C-H bonds to C-C bonds by carbene 
insertion was demonstrated, capable of high stereo-specificity.(26) Evolutionary campaigns on 
this artificial iridium metalloenzyme generated variants with an impressive 4000 fold increase 
in catalytic efficiency (defined by the kcat/KM), with kinetic parameters and selectivities 
Barker_06a_SC.docx  ACCEPTED MANUSCRIPT  22/06/2020 
Johnson Matthey Technol. Rev., 2020, 64, (4), xxx‐yyy  9/23 
Doi: 10.1595/205651320X15928204097766  
matching those of native enzymes. These parameters highlight the potential of this attachment 
method, and in particular the advantages of introducing exogenous metal cofactors with non-
protein ligands remaining coordinated upon ArM formation. 
In this case, the mutations made to this iridium CYP119 metalloenzyme have greatly optimised 
the binding and pre-organisation of the substrate for catalysis, lowering the value for KM, 
(Figure 3). In this system there is no direct iridium-protein coordination; the iridium metal is 
coordinatively saturated by four haem nitrogens, one methyl ligand and coordination to the 
substrate. Therefore, the moderate increase in kcat cannot have come through an electronic 
(through bond) contribution to catalysis from amino acid side chain ligands and protein fold 
energy but must arise from other minor contributors as discussed in the previous section. 
Another limitation of such a system is that it does not allow for the metal to interact with more 
than one substrate at a time, an essential feature of many interesting organometallic 
transformations e.g. metathesis. 
 
Figure 3 | Comparisons between the activities of a bare cofactor and artificial metalloenzyme before and 
after directed evolution | The data in this figure are taken from the work from Hartwig et.al.(26) This elegant 
study is a good example of the issues encountered when using fully substituted artificial cofactors, even in highly 
optimized systems. Whereas directed evolution was able to achieve an impressive 4000-fold increase in kcat/KM, 
the actual chemical turnover rate (kcat) was only moderately enhanced when compared to the cofactor in solution. 
This can be explained by the enzyme evolving to more strongly bind the substrate and optimize the orientation of 
the substrate-metal complex. However, as there is no direct metal-protein interface, directed evolution cannot 
influence the metal chemistry, capping the chemical potential at that observed for the free cofactor in solution.  
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Supramolecular, Non-Covalent Binding of Tagged Complexes 
 
Figure 4 | Schematic representation of supramolecular assembly | The metal cofactor (red) is localised by 
non-covalent interaction between a ligand bound recognition group (blue) and the protein. 
There are many specific complexes between proteins and small molecules which are well 
understood and have very high affinity. Artificial metalloenzymes have therefore been 
generated where a catalytic metal complex has been attached to a small molecule with high 
affinity for a protein target. (Figure 4) This means of localising the new cofactor into a protein 
scaffold has been widely explored. Building on the work of Wilson and Whitesides in the 
1970’s,(35) Thomas Ward and co-workers have assembled ArMs based on the high 
supramolecular affinity of small molecule biotinylated metal catalysts for the protein 
streptavidin. As many as 12 different catalytic transformations have been performed by these 
metal-streptavidin hybrids, including ruthenium catalysed olefin metathesis,(36) ruthenium-
catalysed deallylation,(37) iridium-catalysed transfer hydrogenation(25) and dirhodium-
catalysed cyclopropanation,(38) all in vivo. 
This strategy has also been employed in ArMs that were reported by Tanaka et al. for potential 
therapeutic application. In this example, a coumarin derivative tagged with a ruthenium 
metathesis catalyst was localised to a hydrophobic binding site in human serum albumin. The 
metalloenzyme was directed to cancerous tissue (through specific glycosylation) and a pro-
drug was administered which upon metathesis induced cellular death.(39) 
One key benefit to supramolecular assembly is apparent in the examples described above, and 
that is that the conjugation between metal and protein is robust enough to be performed in 
complex cellular environments. Furthermore, unlike covalent attachment, supramolecular 
assembly can be a reversible process, which allows for component recycling. In a recent report 
of Duhme-Klair et al. catalytic transfer hydrogenation is demonstrated from a siderophore–
protein combination that enables strong but redox-reversible catalyst anchoring.(40) All 
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current examples of ArMs generated by supramolecular assembly do, however, rely on the 
assembly of proteins with known, highly catalytically active metal complexes. As discussed 
previously, using complexes which maintain their ligand set during ArM formation does not 
allow the metal complex to be subjected to evolutionary pressures limiting the evolutionary 
potential. 
Covalent Anchoring Through Metal Ligands 
 
Figure 5 | Schematic representation of covalent anchoring | The metal cofactor (red) is attached to the protein 
by a reaction forming a covalent bond, for instance nucleophile (Nu) attacking an electrophile (E). 
Covalent anchoring relies on using a chemical reaction to covalently link a protein side chain 
to a strong ligand for a metal. (Figure 5) Covalent anchoring methods can be split into two 
broad categories: (i) modification of a natural amino acid side chain (e.g. cysteine, lysine or 
tyrosine), via a nucleophilic– electrophilic reaction and (ii) coupling through a genetically 
encoded unnatural amino acid (UAA). 
There is a resurgence in research for developing novel bioconjugation and protein modification 
techniques of natural amino acids (e.g. cysteine, lysine or tyrosine).(41, 42) Generating ArMs 
through cysteine modification is attractive due to the high nucleophilicity and rarity of free 
cysteines allowing for greater control of reactivity. Salmain and co-workers have modified the 
free Cys25 in the cysteine protease papain, using a variety of Ru, Re and Rh complexes all 
functionalised with either a maleimide or chloroacetamide group.(43–45) 
The pioneering work of the Schultz laboratory enabled incorporation of UAAs into protein 
scaffolds.(46) Since then, the most successful generation of ArMs involving a covalent linkage 
to an UAA were reported by Lewis et al. and involve a reaction between an alkyne-substituted 
dirhodium catalyst and a genetically encoded L-4-azidophenylalanine residue through strain-
promoted azide-alkyne cycloaddition (SPAAC) (47–49) Hypothetically, UAAs could be 
encoded into a specific residue of most proteins; here, the protein scaffold selected was a -
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barrel prolyl oligopeptidase and the resulting metalloenzymes generated catalysed olefin 
cyclopropanation. 
The effectiveness of introducing UAA via stop codon methodology is that theoretically the 
same conjugation technology is applicable to many different proteins to generate diverse 
artificial metalloenzymes through a specific, fast and irreversible covalent conjugation. Beside 
commonly relying on pre-formed metal complexes, an overarching issue of covalent 
attachment and supramolecular assembly is that the protein scaffold is used predominantly as 
an auxiliary providing a chiral and hydrophobic micro-environment. Further, many reported 
methods utilise a long flexible linker between the point of attachment and the metal complex 
which could remove the catalytic centre from the very interactions needed for the protein to 
exert an influence on transition states. 
Direct Activation by Metal Coordination to Protein Side Chains 
 
Figure 6 | Schematic representation of cofactor attachment via direct coordination | The free metal cofactor 
(red) attaches to Lewis basic residues on the protein (LB) via ligand substitution reactions, forming a new metal-
protein complex (blue). 
Dative ArMs have one or more coordination bonds directly from the metal to a Lewis basic 
amino acid residue (His, Cys, Ser, Glu, Asp, etc.) on the protein scaffold (Figure 6). The protein 
therefore has a direct electronic influence on the reactivity at the metal centre. The active hybrid 
molecule is formed by substitution reactions from a precursor metal species and the apoprotein. 
This allows for potentially very clean reaction conditions for assembly of the metal-protein 
complex. Although advances have been made, the complexity of these metal-protein binding 
processes remain a major challenge for the design of competently folded and catalytically 
active metalloproteins from scratch. It is important to distinguish between metalloenzymes 
where coordination to the metal is provided only by amino acid sidechains, substrates and 
solvents, and those in which the metal brings its own specific ligands with it. The latter, metal 
cofactors would be artificial versions of commonly encountered natural examples such as 
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heme, vitamin B12 and molybdopterin which are (bio)synthesised separately and bind to the 
protein through both non-covalent interactions and coordination. As pointed out above, their 
activity is defined by the other ligands they carry to an active site as well as the coordination 
by the protein. 
Degrado and co-workers have pioneered the design of a number of synthetic proteins which 
directly coordinate bare metal atoms or metal cofactors.(50, 51) For example, in some of the 
earliest work, the His3-Zn(II) binding motif found in carbonic anhydrase was introduced into a 
designed four helical bundle protein, and hydrolytic activity was observed.(52) More recently, 
de-novo design has been coupled with directed evolutionary approaches to generate an artificial 
zinc metalloenzyme capable of accelerating ester cleavage with un-paralleled catalytic 
efficiency (kcat / KM – 106 M-1s-1).(27) 
In a range of studies,(53–56) Roelfes and co-workers use amber stop codon technology to 
introduce the UAA (2,2′-bipyridin-5yl)alanine into a range of protein scaffolds. Upon addition 
of different bare metal ions, they were able to obtain ArMs catalysing the Friedel-Craft 
alkylation of indoles, enantioselective metallohydration and the stabilisation of a semiquinone 
radical. By the use of sophisticated computational design, the group was able to introduce 
beneficial point mutations in many of the novel hybrid molecules, improving both 
enantioselectivity and yield. The advances in stop codon technology to introduce UAAs, 
especially in the context of directed evolution, make their use a promising option and provides 
an enticing method for expanding the ligand set available to the protein scaffold.(57–59) In 
another study, Reetz and co-workers computationally designed a copper (II) ion binding site 
into the thermostable protein imidazole glycerol phosphate synthase.(60) The resulting ArM 
was able to catalyse the Diels-Alder cycloaddition of an azachalcone and cyclopentadiene with 
medium selectivity, however, to our knowledge no subsequent directed evolution experiments 
have been reported. 
In contrast to these examples of forming the complete coordination sphere by binding a bare 
metal to the apoprotein state of the ArM, to the best of our knowledge there are no examples 
of adding exogenous metal complexes (particularly 4d and 5d metal complexes) as precursor 
cofactors which then show catalytic activity upon direct coordination to a protein. This is a 
particularly attractive methodology as the challenges of taking unnatural ligands such as 
arenes, carbenes and phosphanes into biology become opportunities for expanding the 
repertoire of chemistries available for catalysis. Controlling the ligand exchange behaviour of 
4d and 5d metal complexes with protein side chain ligands is challenging, not least because the 
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bonds are often stronger and hence exchange rates are slow. This, however, remains an exciting 
area of research due to the catalytic diversity demonstrated by many 4d and 5d metal 
complexes. In this specific area our own work has focused upon ruthenium complexes and their 
ligand exchange behaviour with biological systems, laying the foundation for future work into 
artificial metalloenzymes with direct metal-protein coordination.(61, 62)  
Summary and Outlook  
Significant advances in the incorporation of organometallic complexes into proteins in order 
to generate artificial metalloenzymes have been made. The studies highlighted above reliably 
create hybrid molecules where the stability and turnover number of the metal centre is higher 
than the comparable small molecule organometallic complex in aqueous solution. Maybe 
unsurprisingly, the propensity for side reactions and catalyst decomposition is lowered once 
the complex is in a hydrophobic protein environment, already showcasing the usefulness of 
these hybrid systems. However, the question remains, as to whether or not these strategies 
make full use of the protein component. The unique and numerous demands of ArMs call for 
a highly integrated approach. To date, most of the work described in the literature attempts to 
exploit the chemistry of metal ions and their complexes in a protein scaffold but with limited 
influence from the protein on any catalytic activity because metal-protein coordination is 
largely indirect and so co-operativity is limited. 
The potential for synthetic organometallic chemistry to deliver cofactors which utilise ligand 
chemistry not available to naturally evolved systems can vastly expand the orthogonal catalysis 
available in synthetic biological applications. Using such molecules to embed novel metal-
peptide hybrid complexes in protein scaffolds allows for three-dimensional and electronic 
control around the metal centre that reduces the need for intricate synthetic catalyst generation. 
Instead, control of the steric and electronic environment around the metal ion can be delivered 
via the protein coordination sphere, particularly where a direct coordination bond is used to 
anchor the metal ion to the protein. When combined with the ability to efficiently evolve 
enzymes, a sophisticated organometallic precursor complex together with a suitable apoprotein 
could potentially give rise to a number of diverse reactivities. Therefore, new problems in 
catalysis could be addressed in a faster and more specific manner than with small molecule 
catalysts. Together with non-covalent contributions to catalysis and the intermolecular 
interactions that pre-organise substrates and stabilise transition states, such a system contains 
many readily evolvable components. 
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The majority of protein scaffolds selected for ArM construction have been chosen because of 
their apparent engineerability. However, in most cases the focus seems to lie solely on the 
peptidic component with little consideration for evolution of the metal complex. Although 
methods of selection and directed evolution have been applied, these are often operating on 
already well-defined protein scaffolds that carry an abiotic cofactor but not a direct protein- 
metal complex, which inevitably limits the scope for evolution. Arguably it is desirable, 
therefore, to select for a promiscuous and versatile protein starting point which is not 
constrained by one energy minima but instead can potentially offer numerous distinct metal-
binding environments, both in terms of direct coordination and through secondary, 
intramolecular spheres of influence, ultimately generating differential catalytic ArM activity. 
Performing catalysis with exogenous metal complexes within cellular environments has 
enormous potential applications in medicinal chemistry and synthetic biology. Given the 
potential difficulties associated with cell-uptake, minimising deactivation, overcoming toxicity 
of exogenous metal ions and precise localisation of metal cofactors in cells, the idea of using 
traditionally inert organometallic complexes has obvious advantages in that reactive 
promiscuity is reduced. As pointed out above, such complexes would be designed to have a 
latent catalytic activity which emerges once the metal complex is bound to a protein. The 
design challenges raised by this approach are not just as a result of a need to control the 
electronic and three-dimensional steric coordination sphere of the metal ion, but also to limit 
ligand exchange processes, restricting lability of a precursor complex (in the cellular milieu) 
until it reaches a specific protein target. Since the metal-ligand exchange processes for 4d and 
5d metal complexes are typically slow, they are particularly attractive from this point of view 
but are hard to predict ab initio. 
In conclusion, in order to optimise the chemistry and biochemistry of artificial metalloenzymes, 
directed evolutionary campaigns coupled with high throughput screening methods rather than 
individually-designed synthetic strategies are much more likely to generate optimised 
orthogonal catalysts for new and efficient metabolic processes. Direct coordination between 
metal ions and enzymes is essential in order to deliver truly interdependent systems, ideally 
where entatic states deliver enhanced reactivity, efficiency and selectivity that cannot easily be 
replicated in conventional, synthetic metal catalysis. Going forward, methods of generating 
artificial metalloenzymes should be evaluated and developed for both their ability to be used 
in directed evolution procedures and the extent to which the protein scaffold participates in the 
activity of the metal complex. 
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